Siemens supplies first gas turbine to Iran after lifting of sanctions

Article

Siemens is supplying an F-class gas turbine and transferred the know-how for F-class gas turbine technology under a contract signed with Iran’s MAPNA Group six months ago. It is one of the two gas turbines which Siemens will supply to MAPNA, an Iranian energy and infrastructure conglomerate, along with two generators and the associated power plant instrumentation and controls.

The gas turbine will be used in a 600 MW power station being built in the Iranian port of Bandar Abbas on the Persian Gulf, Siemens said.

Siemens signed a far-reaching agreement with MAPNA in March to collaborate on the transfer of know-how for the F-class gas turbine technology to modernize the Iranian power supply system.

Siemens’ activities in Iran go back as far as 1868 and involve important infrastructure projects, CEO of the Siemens Power and Gas Division Willi Meixner said on Tuesday.

“With the delivery of the first gas turbine to Iran we are renewing our long-term partnership with MAPNA with the aim of modernizing and expanding the country’s power supply network,” he said.

Siemens was one of the first major companies to agree on a deal with Iran after the lifting of sanctions in January, signing a $1.6 billion memorandum of understanding on Iran’s rail infrastructure and a long-term roadmap with MAPNA on the power sector.

Siemens has shipped the first F-class gas turbine for the Bandar Abbas power plant to Iran.

Siemens said the agreement with MAPNA Group included a license for manufacturing F-class gas turbines in Iran. More than 20 gas turbines as well as the associated generators are scheduled to be delivered over the next four to five years, it said.

The German industrial group suspended its cooperation with Iran in 2010 due to sanctions, but has resumed it since the sanctions were lifted.

In February, Siemens was finally able to deliver 30 gas compressors that were intended for the South Pars gas project.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.